Abstract
Abnormal inflammation and oxidative stress are involved in various diseases. Papaver rhoeas L. possesses various pharmacological activities, and a previously reported analysis of the anti-inflammatory effect of P. nudicaule ethanol extracts and alkaloid profiles of the plants suggest isoquinoline alkaloids as potential pharmacologically active compounds. Here, we investigated anti-inflammatory and antioxidant activities of ethyl acetate (EtOAc) fractions of P. nudicaule and P. rhoeas extracts in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. EtOAc fractions of P. nudicaule and P. rhoeas compared to their ethanol extracts showed less toxicity but more inhibitory activity against LPS-induced nitric oxide production. Moreover, EtOAc fractions lowered the LPS-induced production of proinflammatory molecules and cytokines and inhibited LPS-activated STAT3 and NF-κB, and additionally showed significant free radical scavenging activity and decreased LPS-induced reactive oxygen species and oxidized glutathione. EtOAc fractions of P. nudicaule increased the expression of HO-1, GCLC, NQO-1, and Nrf2 in LPS-stimulated cells and that of P. rhoeas enhanced NQO-1. Furthermore, metabolomic and biochemometric analyses of ethanol extracts and EtOAc fractions indicated that EtOAc fractions of P. nudicaule and P. rhoeas have potent anti-inflammatory and antioxidant activities, further suggesting that alkaloids in EtOAc fractions are potent active molecules of tested plants.
Keywords: Papaver nudicaule, Papaver rhoeas, anti-inflammatory, antioxidant, STAT3, NF-κB, Nrf2
1. Introduction
The inflammatory response protects the body against harmful external substances by secreting various inflammatory mediators by immune cells; however, an uncontrolled response can result in excessive cellular/tissue damage that leads to chronic inflammation and destruction of normal tissue [1]. The overproduction of pro-inflammatory mediators in chronic inflammation has been associated with the onset of chronic degenerative diseases, such as arthritis, atherosclerosis, asthma, Alzheimer’s disease, and others [1,2,3,4,5]. During inflammation, the macrophages mainly promote the production of pro-inflammatory mediators, including interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, reactive oxygen species (ROS), nitric oxide (NO), and prostaglandin E2 (PGE2) [6].
Another key component of inflammation is oxidative stress, which reflects an imbalance in ROS, which reduces the production of antioxidant enzymes that protect tissues from oxidative damage [7,8]. In particular, the induction of phase 2 detoxifying enzymes and cytoprotective genes, such as heme oxygenase-1 (HO-1), glutamate-cysteine ligase catalytic (GCLC), and NAD(P)H quinone oxidoreductase 1 (NQO1), is mediated by nuclear factor erythroid-2-related factor 2 (Nrf2), which plays a central role in protecting cells from inflammatory and oxidative damage [9,10,11]. Therefore, developing anti-inflammatory agents and antioxidants that can control the activation of macrophages for preventing and treating various diseases is crucial.
Papaver rhoeas L. (P. rhoeas) and Papaver nudicaule L. (P. nudicaule) in the Papaver genus of the Papaveraceae family have been widely used for ornamentation owing to their multicolored flowers [12]. These plants have been treated as folk medicines for a long time. P. rhoeas has been used to treat inflammation, cough, diarrhea, respiratory problems, asthma, insomnia, and pain, and also consumed as food [13,14,15,16]. P. nudicaule has been used as a mild diaphoretic and a source of vitamin C [17,18]. Papaver species produce various alkaloids, particularly isoquinoline alkaloids, which have potent pharmacological activities such as narcotic analgesic, antimicrobial, cough suppressant, and anticancer effects [15,19,20,21,22]. Recent studies have also confirmed various pharmacological effects of P. rhoeas extracts, including antioxidant, cytoprotective, antimicrobial, antimutagenic, anti-analgesic, and antiulcerogenic activities [15,19,23,24,25,26,27]. However, few biological activities of P. nudicaule have been reported. We recently reported decreased response of lipopolysaccharide (LPS)-induced inflammation by ethanol (EtOH) extracts of P. nudicaule by inhibiting the signal transducer and activator of transcription 3 (STAT3) and nuclear factor-kappa B (NF-κB) pathways [28]. However, EtOH extracts of P. rhoeas did not show any effect on LPS-induced inflammation in RAW264.7 macrophage cells (data not shown). In addition, EtOH extracts of both Papaver species did not exhibit antioxidant activity in our system (data not shown). Although both P. rhoeas and P. nudicaule are known to produce pharmacologically active alkaloids, EtOH extraction might not be sufficient for biological activities. Therefore, in the current study, liquid-liquid extraction (LLE)-based ethyl acetate (EtOAc) fractions from EtOH extracts of P. rhoeas and P. nudicaule were prepared to enrich alkaloids, and their potential anti-inflammatory and antioxidant activities were examined.
2. Materials and Methods
2.1. Plant Materials and Sample Preparation
P. nudicaule and P. rhoeas were collected by the Korea National Academy of Agricultural Science, Rural Development Administration. The five cultivars of P. nudicaule and P. rhoeas samples were immediately freeze-dried after washing with clean water. The EtOH extractions of each ten-gram finely ground sample of aerial parts of lyophilized Papaver species were performed as previously described [28]. Each EtOH extract was thereafter suspended in distilled H2O and polar phase sequentially partitioned with n-hexane and EtOAc (Table 1).
Table 1.
Species | Flower Color | Abbreviation of Ethanolic Extract | Abbreviation of EtOAc Fraction From Each Ethanolic Extracts |
---|---|---|---|
Papaver rhoeas | Red | RA | RA-Fr |
Papaver nudicaule | White | NW | NW-Fr |
Papaver nudicaule | Pink | NP | NP-Fr |
Papaver nudicaule | Scarlet | NS | NS-Fr |
Papaver nudicaule | Yellow | NY | NY-Fr |
Papaver nudicaule | Orange | NO | NO-Fr |
2.2. Cell Culture and Reagents
RAW264.7 murine macrophage cells (Korean Cell Line Bank, Seoul, Republic of Korea) were cultured as previously described [28]. 3-(4,5-dimethylthiazol-2-yl)- and 5-diphenyl-tetrazolium bromide (MTT) and LPS (Escherichia coli serotype 0111: B4) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
2.3. Cell Viability Assays
MTT assays were performed to measure cell viability in RAW264.7 cells (1 × 104 cells/well in 96-well plates) after treatment with EtOH extracts or EtOAc fractions of P. nudicaule and P. rhoeas for 24 h as previously described [28]. Data are presented as mean ± the standard error of the mean (SEM) from at least three independent experiments in triplicates.
2.4. Nitric Oxide Assays
A NO detection kit (iNtRON Biotechnology, Sungnam, Republic of Korea) was used for measuring the nitrite concentration in the culture supernatant as an indicator of NO production. NO assays in RAW264.7 cells (5 × 105 cells/well in 6-well plates) were performed at least three independent experiments in triplicate according to the instructions of the manufacturer and also as previously described [28]. Data are presented as mean ± SEM.
2.5. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Free Radical Scavenging Activity
The free radical scavenging activity of the EtOAc fraction of P. nudicaule and P. rhoeas was evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) analysis. Briefly, 150 μL of 10 μM DPPH (Sigma Aldrich, St. Louis, MO, USA) was added to 150 μL of serial dilution samples, and ascorbic acid was used as a positive control because it is a well-known antioxidant. The mixture was then incubated at room temperature for 15 min in the dark. The absorbance of each sample solution was measured at 515 nm using a microplate reader. The free radical scavenging activity was calculated as follows: DPPH radical scavenging activity (%) = (Ablank − Asample)/Ablank × 100 (Ablank: the absorbance of the DPPH solution and Asample: the absorbance of the test sample). Data are presented as the mean ± SEM from at least three independent experiments in triplicate.
2.6. GSH/GSSG Ratio
Glutathione/glutathione disulfide (GSH/GSSG) ratios were detected and quantified using the GSH/GSSG-Glo™ assay (Promega, Southampton, UK). Cells were pretreated with EtOAc fractions of P. nudicaule or P. rhoeas 1 h prior to LPS (5 ng/mL) treatment for 12 h. Thereafter, the media were discarded and replaced with either total glutathione lysis reagent or oxidized glutathione lysis reagent, and cells were agitated for 5 min. Both plates were kept at room temperature for 30 min before the luciferin generation reagent was added. Next, the luciferin detection reagent was introduced and incubated for 15 min, following which luminescence was measured (integration time = 0.3 s). The GSH/GSSG ratio was calculated as follows: GSH/GSSG ratio = (µM total glutathione treated − (µM GSSG-treated × 2))/µM GSSG-treated.
2.7. Measurement of Intracellular ROS
Intracellular ROS production was measured using 2,7-dichlorofluorescein diacetate (DCF-DA). This substrate freely permeates the cells, and upon incorporation, is oxidized to fluorescent DCF. Cells were pre-incubated with EtOAc fractions of P. nudicaule or P. rhoeas for 1 h and then incubated with LPS (5 µg/mL) for 18 h. Cells were then stained with 20 µM DCF-DA (Sigma-Aldrich, #D6883, St. Louis, MO, USA) for 30 min at 37 °C in the dark, following which they were collected, washed twice with PBS, and subjected to an analysis of a total of 10,000 events using a flow cytometer (BD Biosciences, San Jose, CA, USA). To confirm the involvement of elevated ROS in the LPS-induced inflammatory response, cells were pre-incubated with ascorbic acid (100 µM), an established antioxidant, for 1 h prior to LPS treatment.
2.8. Real-Time Quantitative PCR
RAW264.7 cells (5 × 105 cells/well) were seeded in 6-well plates and incubated overnight. The cells were then pretreated with EtOAc fractions of P. nudicaule or P. rhoeas 1 h prior to LPS (5 or 10 ng/mL) treatment for 4 or 8 h. Isolation of total RNA using the TRI Reagent solution (Ambion, Waltham, MA, USA), its reverse transcription to cDNA using the PrimeScript first-strand cDNA synthesis kit (Takara Korea Biomedical Inc., Seoul, Republic of Korea), and amplification of each cDNA and monitoring using a Sensi FAST SYBR No-ROX kit (Bioline, Taunton, MA, USA) on a StepOnePlus instrument (Waltham, MA, USA) were previously described [28]. Specific primers used as follows: HO-1 (forward: 5′-AAGCCGAGAATGCTGAGTTCA-3′ and reverse: 5′-GCCGT GTAGATATGGTACAAGGA-3′), GCLC (forward: 5′-GTCCTCAGGTGACATTCCAAG C-3′ and reverse: 5′-TGTTCTTCAGGGGCTCCAGTC-3′), and NQO1 (forward: 5′-GGCAGAAGAGCACTGATCGTA-3′ and reverse: 5′-TGATGGGATTGAAGTTCATGGC-3′). Specific primers used for IL-6, TNF-α, IL-1β, and GAPDH were previously described [28]. Data are presented as mean ± SEM from at least three independent experiments in triplicate.
2.9. Preparation of Nuclear and Cytosolic Extracts
RAW264.7 cells were lysed with 200 μL of 10 mM KCl, 0.2 mM EDTA, 1.5 mM MgCl2, 0.5 mM DTT, and 0.2 mM phenylmethylsulfonyl fluoride (PMSF) at 4 °C for 30 min. The lysates were then centrifuged for 5 min at 14,000× g, and the supernatants were stored as the cytosolic extracts at −70 °C. The resulting pellets were re-suspended in 30 μL of ice-cold 20 mM HEPES (pH 7.9), 420 mM NaCl, 1.5 mM MgCl2, 20% (v/v) glycerol, 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM PMSF. After incubation at 4 °C for 30 min, the lysates were centrifuged for 10 min at 14,000× g, and the supernatants were stored as nuclear extracts at −70 °C. Concentrations of the cytosolic and nuclear extracts were determined using a BCA kit (Bio-Rad, Richmond, CA, USA).
2.10. Western Blotting Analysis
Cells were pre-treated with EtOAc fractions of P. nudicaule or P. rhoeas for 1 h and then incubated with LPS (5 ng/mL) for 30 min–24 h. Nuclear, cytoplasmic, and whole-cell extracts were prepared, and western blotting was performed as described previously [29]. Primary antibodies against Nrf2, lamin B, cyclooxygenase (COX) 2, inducible NO synthase (iNOS), p65, phospho (p)-p65, IκBα, p-IκBα, STAT3, and p-STAT3 were purchased from Cell Signaling Technology (Danvers, MA, USA). β-actin was from Sigma-Aldrich (Sigma-Aldrich, St. Louis, MO, USA). HRP-conjugated anti-mouse IgG and anti-rabbit secondary antibodies (1:5000–1:10,000) were from Jackson Immuno Research Laboratories, Inc. (West Grove, PA, USA). ImageJ software (https://imagej.nih.gov/ij/, accessed on 5 November 2021). was used for densitometric analysis of each protein band. Data are presented as mean ± Standard Deviation (SD) from at least three independent experiments.
2.11. Enzyme-Linked Immunosorbent Assay (ELISA) Assays
Cells (5 × 105 cells/well in 6-well plates) were pre-incubated with EtOAc fractions of P. nudicaule or P. rhoeas for 1 h and incubated with LPS (5 ng/mL) for 24 h. Analysis of PEG2 secretion using an ELISA kit for PGE2 (Biochem Inc., Farmingdale, NY, USA) was performed according to the manufacturer’s instructions and as described previously [28]. Data are presented as mean ± SEM from at least three independent experiments in triplicate.
2.12. Statistical Analysis
Every experiment was performed at least three independent times in triplicate. SigmaPlot 10.0 software (Systat Software, Inc., San Jose, CA, USA) was used to perform an unpaired Student’s t-test between control and LPS treatment or LPS alone and co-treatment of EtOAc fractions or EtOH extracts of P. nudicaule and P. rhoeas with LPS to calculate the p-value. p < 0.05 was used as a statistically significant level.
2.13. Investigation and Identification of Bioactivity-Specific Metabolites
To investigate the anti-inflammatory and antioxidant properties of phytochemicals, liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based alkaloid profiling of EtOH extracts and EtOAc fractions was performed using chromatographic analysis, as previously reported [22]. Profiling data acquired from 12 samples, including EtOH extracts and EtOAc fractions of P. nudicaule and P. rhoeas in the untargeted scan were processed using MarkerView 1.3.1 (SCIEX, Foster City, CA, USA). To correlate alkaloid profiles and associated biological data of all extracts and fractions, biochemometric analysis was performed, where processed metabolites data including m/z, retention time, and peak area were merged with each of the bioactive data of NO, ROS, and PGE2 evaluations to form the final matrix for the investigation of bioactivity-specific metabolites. The Pearson method was used for metabolite and biological activity correlation analyses. The significant differences between the EtOAc and EtOH groups were evaluated using a t-test with Bonferroni correction. All statistical analyses were performed using R software (version 4.1.0; http://cran.r-project.org/bin/windows/base/old/4.1.0, accessed on 5 November 2021; R Foundation for Statistical Computing, Vienna, Austria). Mass spectrometric identification was performed in positive ion mode using PeakView and MasterView software (SCIEX, Foster City, CA, USA) and molecular networking analysis.
3. Results
3.1. EtOAc Fractions of P. nudicaule and P. rhoeas Reduce the LPS-Induced NO and PGE2
To investigate the potential antioxidant and anti-inflammatory effects of P. nudicaule and P. rhoeas, we first checked the cytotoxicity of each EtOH extract and EtOAc fraction of both plants in RAW264.7 cells. As shown in Figure 1a, the EtOAc fractions of the plants were generally less toxic than their corresponding EtOH extracts. The EtOAc fractions were not cytotoxic up to 25 μg/mL (NW-Fr, NP-Fr, and NO-Fr) and 50 μg/mL (RA-Fr, NS-Fr, NY-Fr), whereas the EtOH extracts were harmless up to 3.125 μg/mL (RA), 6.25 μg/mL (NW), and 12.5 μg/mL (NP, NS, NY, and NO). Based on these results, the non-toxic concentrations of each EtOH extract and EtOAc fraction of the plants were used for further investigation.
Furthermore, antioxidant and anti-inflammatory effects of EtOH extracts and EtOAc fractions of P. nudicaule and P. rhoeas were evaluated by measuring their inhibitory effects on LPS-induced NO production in RAW264.7 cells, and the results suggest the better performance of EtOAc fractions of P. nudicaule and P. rhoeas than of EtOH extracts. As shown in Figure 1b, every EtOH extract of P. nudicaule and P. rhoeas showed a statistically significant but marginal effect on reducing LPS-mediated NO production. In contrast, EtOAc fractions of P. nudicaule and P. rhoeas significantly reduced LPS-induced NO production in a dose-dependent manner, and the inhibitory effect of every cultivar of P. nudicaule was better than that of P. rhoeas (Figure 1b). In addition, the EtOAc fraction of NO (NO-Fr) among the five cultivars of P. nudicaule had the best inhibitory effect (86.8% inhibition at 25 µg/mL) of LPS-induced NO production in RAW264.7, and NS-Fr (75.5% inhibition at 25 µg/mL) and NY-Fr (75.8% inhibition at 25 µg/mL) were slightly better than the other two. Thus, RA-Fr, NO-Fr, and NS-Fr were selected and used to further investigate the antioxidant and anti-inflammatory effects of P. nudicaule and P. rhoeas.
Since iNOS is responsible for certain cytokine- or microbial product-mediated NO production and NO is known to increase prostaglandin production via the COX pathway in macrophages [30,31], we examined the effects of RA-Fr, NO-Fr, and NS-Fr on the LPS-induced expression of PGE2, COX2, and iNOS in RAW264.7 cells. As shown in Figure 2a, all EtOAc fractions significantly reduced LPS-induced PGE2 in a dose-dependent manner. In addition, every fraction suppressed the LPS-induced expression of iNOS and COX2 (Figure 2b–d) as expected. In particular, NO-Fr was the most effective in reducing LPS-induced PGE2, iNOS, and COX2, similar to the suppression of LPS-induced NO. Together, these results suggest that the EtOAc fractions of both P. nudicaule and P. rhoeas might be potent antioxidants and anti-inflammatory agents.
3.2. EtOAc Fractions of P. nudicaule and P. rhoeas Reduced LPS-Induced Inflammatory Cytokines and Inhibited the LPS-Mediated Activation of NF-κB and STAT3
To further elucidate the anti-inflammatory effects of EtOAc fractions of P. nudicaule and P. rhoeas and their mechanism of action, we examined mRNA expression levels of proinflammatory cytokines IL-1β, IL-6, and TNF-α. As shown in Figure 3, NO-Fr, NS-Fr, and RA-Fr effectively reduced the LPS-induced mRNA expression of IL-1β, IL-6, and TNF-α, indicating that these cultivars could regulate the expression of these genes at the transcriptional level. NF-κB and STAT3 are transcription factors that regulate the expression of the proinflammatory cytokines as well as COX2 and iNOS [28,32,33]. In addition, TNF-α and IL-6 activate NF-κB and STAT3 signaling pathways [34]. Thus, we investigated the effects of NO-Fr, NS-Fr, and RA-Fr on LPS-induced activation of NF-κB and STAT3. As shown in Figure 4a,c, the aforementioned cultivars suppressed the LPS-induced phosphorylation levels of STAT3, but had no effect on the expression of STAT3, indicating EtOAc fractions of the plant-mediated inactivation of STAT3. They also reduced the LPS-induced phosphorylation levels of IκBα and p65, indicating EtOAc fractions of the plant-mediated inactivation of NF-κB. These results suggest that the EtOAc fractions of both P. nudicaule and P. rhoeas exert their anti-inflammatory effects in LPS-stimulated macrophage cells by inhibiting NF-κB and STAT3.
3.3. EtOAc Fractions of P. nudicaule and P. rhoeas Reduce Oxidative Stress
Oxidative stress occurs as a result of an imbalance between generated reactive metabolites, also known as ROS, and the body’s antioxidant system. ROS, such as superoxides, hydrogen peroxide, and hydroxyl free radicals, are constantly produced in aerobic organisms. Elevated levels of ROS and free radical oxidative damage boost the generation of proinflammatory conditions and cause disease progression [10,33]. For this reason, we next investigated the potential antioxidant activities of NO-Fr, NS-Fr, and RA-Fr by measuring DPPH free radical scavenging activity. As shown in Figure 5a, the DPPH radical scavenging activity increased up to approximately 35% by ascorbic acid, a positive control. Although less than ascorbic acid, DPPH radical scavenging activities of NO-Fr, NS-Fr, and RA-Fr were observed in a dose-dependent manner (Figure 5a). We also examined the intracellular ROS in LPS-stimulated RAW264.7 cells to confirm the antioxidant activity of NO-Fr, NS-Fr, and RA-Fr. As shown in Figure 5b, NO-Fr, NS-Fr, and RA-Fr significantly decreased the LPS-increased intracellular ROS in a dose-dependent manner, and their activities were better than that of ascorbic acid. In addition, NO-Fr, NS-Fr, and RA-Fr remarkably recovered the decrease in the GSH/GSSG ratio lowered by LPS treatment in RAW264.7 cells, indicating a reduction in LPS-induced oxidative stress. These results indicated good anti-oxidative effects of the EtOAc fractions of both P. nudicaule and P. rhoeas.
3.4. EtOAc Fractions of P. nudicaule and P. rhoeas Increases the Expression of Antioxidant Regulators by Activating Nrf2
Nrf2 signaling plays a vital role in intracellular antioxidant systems, including HO-1, NQO1, and GCLC [9,10,11]. Thus, we further investigated the mechanism by which NO-Fr, NS-Fr, and RA-Fr induced the antioxidant effects. As shown in Figure 6a, NO-Fr and NS-Fr increased the mRNA expression levels of HO-1, GCLC, and NQO1, and RA-Fr increased the expression of NQO1 in LPS-stimulated RAW264.7 cells. As the expression of antioxidant regulators is regulated by Nrf2 [8,9,11], we examined the expression of Nrf2 in the cytoplasm and nucleus of LPS-stimulated cells and found that NO-Fr and NS-Fr significantly increased Nrf2 expression in the nucleus but not in the cytoplasm, while RA-Fr had no effect on the expression of Nrf2 in both the cytoplasm and nucleus (Figure 6b,c). These results suggest that the EtOAc fraction of P. nudicaule exerts antioxidant effects via the Nrf2-mediated induction of antioxidant genes, whereas the EtOAc fraction of P. rhoeas had an Nrf2-independent increase in NQO1.
3.5. Investigation and Identification of Bioactivity-Specific Metabolites
The introduction of biochemometric analyses to natural products in extracts or fractions provides an opportunity to unravel potential multiple effects of multi-components and provide potential markers in various components [35,36]. To investigate antioxidant- and anti-inflammation-specific metabolites in P. nudicaule, their metabolites and bioactivity (NO, PGE2, and ROS) from the EtOH extract and EtOAc fractions were linked using Pearson’s correlation and compared to those of P. rhoeas. The Pearson correlation coefficient between the metabolite levels in the two groups, including 12 samples, and each bioactivity was calculated. Values of r > 0.7 (or r < −0.7) confirm that a strong correlation between metabolite and bioactivity exists, and values between 0.3 and 0.7 (−0.3 and −0.7) confirm a moderate correlation, whereas values of r < 0.3 (or r > −0.3) affirm a weak correlation. The processed metabolomic data included 876 metabolites. Among them, 493 metabolites showed a strong negative correlation between the EtOAc group and inhibitory effects on LPS-induced NO production. Identifying relevant active molecules from complex mixtures represents a major challenge in natural product drug discovery [22,37,38], and identified metabolites (Table S1) were labeled on the integrated correlation to obtain potent bioactive compound information and dereplicate effectively (Figure 7a). To investigate potentially bioactive metabolites in compound mixtures from EtOAc fractions and EtOH extracts, significant metabolites represent potent metabolites with a statistically significantly strong biochemometric value (strong Pearson correlation value (r < −0.7) and significance (FDR-corrected, p value < 0.05)) and a higher average of peak area. Each EtOAc fraction of P. nudicaule and P. rhoeas was compared to their EtOH extracts according to the inhibitory effects on LPS-induced NO production in RAW264.7 cells. Finally, seven metabolites, including sanguinarine, tetrahydropalmatine, hydroxysanguianrine, orientalidine, dihydrosanguinarine, N-trans-p-coumaroyltyramine, and tetrahydrocolcumbanine were investigated and showed a strong significant correlation with inhibition of LPS-induced NO and PGE2. Sanguinarine, tetrahydropalmatine, N-trans-p-coumaroyltyramine, and tetrahydrocolcumbanine additionally presented a significant correlation with the reduction of ROS. Variations in the levels of significant metabolites in the samples are shown in Figure 7b. The content of metabolites in EtOAc fractions of P. nudicaule are relatively higher than the others, except for tetrahydropalmatine.
4. Discussion
Various pharmacological effects of P. rhoeas extracts, including antioxidant, cytoprotective, antimicrobial, antimutagenic, anti-analgesic, and antiulcerogenic activities have been uncovered [15,19,23,24,25,26,27]. However, the EtOAc fraction of the P. rhoeas EtOH extracts has not been evaluated for its pharmacological effects. Our recent reports presented the anti-inflammatory effects of the P. nudicaule EtOH extract, and metabolite profiling of P. rhoeas and P. nudicaule suggested isoquinoline alkaloids as potential pharmacologically active compounds in the plants [22,28,38]. In the current study, liquid-liquid extraction-based EtOAc fractions from EtOH extracts of P. nudicaule and P. rhoeas were prepared to enrich alkaloids. EtOAc fractions of the plants compared to their EtOH extracts showed less toxicity but more inhibitory activity against LPS-induced NO production (Figure 1). NO is produced in large quantities during inflammation and interacts with other ROS to produce reactive nitrogen oxide species [39,40]. Therefore, it can be hypothesized that the reduction of NO is involved in anti-inflammatory and antioxidant responses. EtOAc fractions of both plants lowered the LPS-induced production of proinflammatory molecules (Figure 2) and cytokines (Figure 3) and inhibited LPS-activated STAT3 and NF-κB (Figure 4). NF-κB and STAT3 are crucial transcription factors involved in immune response and inflammatory diseases by regulating the expression of inflammation-related genes, including COX2, iNOS, and inflammatory cytokines [34,41]. These results indicated that EtOAc fractionations of P. nudicaule and P. rhoeas compared to their EtOH extracts showed much better anti-inflammatory effects through inhibiting both NF-κB and STAT3, and suggest that alkaloids of the plants can be a very attractive strategy for use in inflammatory diseases.
ROS, such as superoxide, hydrogen peroxide, and hydroxyl free radicals, are constantly produced in aerobic organisms [42,43]. Hyperinflammatory responses reduce the production of antioxidant enzymes that in turn protect tissues from oxidative damage [8,11]. Nrf2 protects cells from stressors, including endogenous substances, ROS, radiation, environmental toxins, and xenobiotics from food [11]. Nrf2 accumulates in the nucleus, where it dimerizes with small Maf proteins and binds to antioxidant response element cis-regulatory sequences to trigger transcriptional expression [44]. A large number of genes have been identified as downstream targets of Nrf2, including NQO1 and HO-1. Additionally, NF-κB signaling inhibits the antioxidant effect by inhibiting the Nrf2-Keap1 pathway through the interaction of p65 and Keap1 [45,46]. EtOAc fractionations of P. nudicaule and P. rhoeas showed significant free radical scavenging activity and decreased LPS-induced reactive oxygen species and oxidized glutathione (Figure 5). EtOAc fractions of P. nudicaule increased the expression of HO-1, NQO-1, GCLC and nuclear Nrf2 in LPS-stimulated cells, while that of P. rhoeas enhanced only NQO-1 (Figure 6). Together, these results suggest that EtOAc fractions of P. nudicaule exert antioxidant effects via the Nrf2-mediated induction of antioxidant genes, whereas the EtOAc fraction of P. rhoeas had a Nrf2-independent increase in NQO1, probably by inhibiting NF-κB.
Moreover, EtOAc fractions of P. nudicaule compared to the EtOAc fraction of P. rhoeas presented better effects in both antioxidant and anti-inflammatory activity. Therefore, to identify potential candidate alkaloids involved in antioxidant and anti-inflammatory effects of P. nudicaule, we investigated antioxidant- and anti-inflammation-specific metabolites of P. nudicaule cultivars. Their metabolites (876 metabolites) and biological activities on LPS-induced NO, PGE2, and ROS production from the EtOH extract and EtOAc fractions were linked using Pearson’s correlation and also compared to those of P. rhoeas. Based on correlation analysis results, important metabolites analyzed using biochemometrics were selected. Among identified potent metabolites, those with changes in the sample’s significant metabolite levels are shown in Figure 7b. Among them, sanguinarine is known to have anti-inflammatory and neuroprotective effects [47,48], and tetrahydropalmatine is known to inhibit oxidative stress and inflammasome activation [49,50]. Dihydrosanguinarine is also known to inhibit pancreatic cancer cells [51]. In addition, 6-acetonyl-5,6-dihydrosanguinarine has been reported to trigger proinflammatory cytokine production [52]. However, other metabolites remain unknown. These metabolites may contribute to antioxidant and anti-inflammatory effects. Therefore, it is necessary to study the mechanism of antioxidant and anti-inflammatory effects through follow-up studies of selected novel metabolites.
5. Conclusions
The current study demonstrates that EtOAc fractions of P. nudicaule and P. rhoeas had lower cytotoxicity compared with their EtOH extracts and exhibited promising antioxidant and anti-inflammatory activities. Metabolomic and biochemometric analyses of the plants suggested seven potential active alkaloids were enriched in the EtOAc fraction of P. nudicaule. These results could serve as the rationale for further investigation of EtOAc fractions of the plants and alkaloids for the development of therapeutic interventions for inflammation-related diseases.
Acknowledgments
We would like to thank Jae-Hyeon Oh (National Institute of Agricultural Science) for providing the P. nudicaule and P. rhoeas samples.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/antiox10121895/s1, Table S1: Identification of chemical components authentically or tentatively in EtOH extracts and EtOAc fractions of P. nudicaule and P. rhoeas from using LC-ESI-QTOF MS/MS.
Author Contributions
Conceptualization, I.J.H. and S.-G.L.; Methodology, H.K., I.J.H. and S.-G.L.; Validation, H.K., S.H., I.J.H. and S.-G.L.; investigation, H.K., S.H., K.S., M.Y.L. and B.P.; resources, I.J.H. and S.-G.L.; data curation, H.K., I.J.H. and S.-G.L.; writing—original draft preparation, H.K.; writing—review and editing, I.J.H. and S.-G.L.; supervision, I.J.H. and S.-G.L.; project administration, I.J.H. and S.-G.L.; funding acquisition, S.-G.L. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by Kyung Hee University (grant number KHU-20191217).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data is contained within the article and Supplementary Materials.
Conflicts of Interest
The authors declare no conflict of interest. The funders had no role in the study design, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish results.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Simpson J.L., Phipps S., Gibson P.G. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol. Ther. 2009;124:86–95. doi: 10.1016/j.pharmthera.2009.06.004. [DOI] [PubMed] [Google Scholar]
- 2.Bone R.C., Grodzin C.J., Balk R.A. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest. 1997;112:235–243. doi: 10.1378/chest.112.1.235. [DOI] [PubMed] [Google Scholar]
- 3.Rock K.L., Kono H. The inflammatory response to cell death. Annu. Rev. Pathol. 2008;3:99–126. doi: 10.1146/annurev.pathmechdis.3.121806.151456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kaplan M.J. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat. Rev. Rheumatol. 2009;5:208–217. doi: 10.1038/nrrheum.2009.29. [DOI] [PubMed] [Google Scholar]
- 5.Amor S., Peferoen L.A., Vogel D.Y., Breur M., van der Valk P., Baker D., van Noort J.M. Inflammation in neurodegenerative diseases—An update. Immunology. 2014;142:151–166. doi: 10.1111/imm.12233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011;11:723–737. doi: 10.1038/nri3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Jones D.P. Redefining oxidative stress. Antioxid. Redox Signal. 2006;8:1865–1879. doi: 10.1089/ars.2006.8.1865. [DOI] [PubMed] [Google Scholar]
- 8.Brune B., Dehne N., Grossmann N., Jung M., Namgaladze D., Schmid T., von Knethen A., Weigert A. Redox control of inflammation in macrophages. Antioxid. Redox Signal. 2013;19:595–637. doi: 10.1089/ars.2012.4785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Loboda A., Damulewicz M., Pyza E., Jozkowicz A., Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell. Mol. Life Sci. 2016;73:3221–3247. doi: 10.1007/s00018-016-2223-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.De S., Manna A., Kundu S., De Sarkar S., Chatterjee U., Sen T., Chattopadhyay S., Chatterjee M. Allylpyrocatechol Attenuates Collagen-Induced Arthritis via Attenuation of Oxidative Stress Secondary to Modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 Pathways. J. Pharmacol. Exp. Ther. 2017;360:249–259. doi: 10.1124/jpet.116.238444. [DOI] [PubMed] [Google Scholar]
- 11.Huang Y., Li W., Su Z.Y., Kong A.N. The complexity of the Nrf2 pathway: Beyond the antioxidant response. J. Nutr. Biochem. 2015;26:1401–1413. doi: 10.1016/j.jnutbio.2015.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bujak T., Zagorska-Dziok M., Ziemlewska A., Niziol-Lukaszewska Z., Wasilewski T., Hordyjewicz-Baran Z. Antioxidant and Cytoprotective Properties of Plant Extract from Dry Flowers as Functional Dyes for Cosmetic Products. Molecules. 2021;26:2809. doi: 10.3390/molecules26092809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Selen Isbilir S., Sagiroglu A. An Assessment of In Vitro Antioxidant Activities of Different Extracts from Papaver rhoeas L. Leaves. Int. J. Food Prop. 2012;15:1300–1308. doi: 10.1080/10942912.2010.520542. [DOI] [Google Scholar]
- 14.Kalav Y.N., Sariyar G. Alkaloids from Turkish Papaver rhoeas. Planta Med. 1989;55:488. doi: 10.1055/s-2006-962072. [DOI] [PubMed] [Google Scholar]
- 15.Çoban İ., Toplan G.G., Özbek B., Gürer Ç U., Sarıyar G. Variation of alkaloid contents and antimicrobial activities of Papaver rhoeas L. growing in Turkey and northern Cyprus. Pharm. Biol. 2017;55 doi: 10.1080/13880209.2017.1340964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.El S.N., Karakaya S. Radical scavenging and iron-chelating activities of some greens used as traditional dishes in Mediterranean diet. Int. J. Food Sci. Nutr. 2004;55:67–74. doi: 10.1080/09637480310001642501. [DOI] [PubMed] [Google Scholar]
- 17.Huang Z., He J., Xia D., Zhong X.-J., Li X., Sun L.-X., Cai S.-Z. Evaluation of physiological responses and tolerance to low-temperature stress of four Iceland poppy (Papaver nudicaule) varieties. J. Plant. Interact. 2016;11:117–123. doi: 10.1080/17429145.2016.1217433. [DOI] [Google Scholar]
- 18.Hedrick U.P. Sturtevant’s Edible Plants of the World. Southwest School of Botanical Medicine; Ithaca, NY, USA: Jul 1, 1972. [Google Scholar]
- 19.Todorova T., Pesheva M., Gregan F., Chankova S. Antioxidant, antimutagenic, and anticarcinogenic effects of Papaver rhoeas L. extract on Saccharomyces cerevisiae. J. Med. Food. 2015;18:460–467. doi: 10.1089/jmf.2014.0050. [DOI] [PubMed] [Google Scholar]
- 20.Saeed-Abadi S., Ranjbaran M., Jafari F., Najafi-Abedi A., Rahmani B., Esfandiari B., Delfan B., Mojabi N., Ghahramani M., Sahraei H. Effects of Papaver rhoeas (L.) extract on formalin-induced pain and inflammation in mice. Pak. J. Biol. Sci. 2012;15:1041–1044. doi: 10.3923/pjbs.2012.1041.1044. [DOI] [PubMed] [Google Scholar]
- 21.Sahraei H., Fatemi S.M., Pashaei-Rad S., Faghih-Monzavi Z., Salimi S.H., Kamalinegad M. Effects of Papaver rhoeas extract on the acquisition and expression of morphine-induced conditioned place preference in mice. J. Ethnopharmacol. 2006;103:420–424. doi: 10.1016/j.jep.2005.08.022. [DOI] [PubMed] [Google Scholar]
- 22.Song K., Oh J.H., Lee M.Y., Lee S.G., Ha I.J. Molecular Network-Guided Alkaloid Profiling of Aerial Parts of Papaver nudicaule L. Using LC-HRMS. Molecules. 2020;25:2636. doi: 10.3390/molecules25112636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Katarzyna J., Karolina J., Patrycja K., Mateusz B., Izabela G. Mineral Composition and Antioxidant Potential in the Common Poppy (Papaver rhoeas L.) Petal Infusions. Biol. Trace Elem. Res. 2021;199:371–381. doi: 10.1007/s12011-020-02134-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Osanloo N., Najafi-Abedi A., Jafari F., Javid F., Pirpiran M., Memar Jafari M.R., Mousavi Khosravi S.A., Rahimzadeh Behzadi M., Ranjbaran M., Sahraei H. Papaver rhoeas L. Hydroalcoholic Extract Exacerbates Forced Swimming Test-Induced Depression in Mice. Basic Clin. Neurosci. 2016;7:195–202. doi: 10.15412/J.BCN.03070304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hasplova K., Hudecova A., Miadokova E., Magdolenova Z., Galova E., Vaculcikova L., Gregan F., Dusinska M. Biological activity of plant extract isolated from Papaver rhoeas on human lymfoblastoid cell line. Neoplasma. 2011;58:386–391. doi: 10.4149/neo_2011_05_386. [DOI] [PubMed] [Google Scholar]
- 26.Pourmotabbed A., Rostamian B., Manouchehri G., Pirzadeh-Jahromi G., Sahraei H., Ghoshooni H., Zardooz H., Kamalnegad M. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice. J. Ethnopharmacol. 2004;95:431–435. doi: 10.1016/j.jep.2004.08.022. [DOI] [PubMed] [Google Scholar]
- 27.Gürbüz İ., Üstün O., Yesilada E., Sezik E., Kutsal O. Anti-ulcerogenic activity of some plants used as folk remedy in Turkey. J. Ethnopharmacol. 2003;88:93–97. doi: 10.1016/S0378-8741(03)00174-0. [DOI] [PubMed] [Google Scholar]
- 28.Oh J.H., Yun M., Park D., Ha I.J., Kim C.K., Kim D.W., Kim E.O., Lee S.G. Papaver nudicaule (Iceland poppy) alleviates lipopolysaccharide-induced inflammation through inactivating NF-κB and STAT3. BMC Complement. Altern. Med. 2019;19:90. doi: 10.1186/s12906-019-2497-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lim S.L., Park S.Y., Kang S., Park D., Kim S.H., Um J.Y., Jang H.J., Lee J.H., Jeong C.H., Jang J.H., et al. Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells. Am. J. Cancer Res. 2015;5:289–299. [PMC free article] [PubMed] [Google Scholar]
- 30.Bogdan C. Nitric oxide synthase in innate and adaptive immunity: An update. Trends Immunol. 2015;36:161–178. doi: 10.1016/j.it.2015.01.003. [DOI] [PubMed] [Google Scholar]
- 31.Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011;31:986–1000. doi: 10.1161/ATVBAHA.110.207449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Park M.H., Hong J.T. Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches. Cells. 2016;5:15. doi: 10.3390/cells5020015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39:44–84. doi: 10.1016/j.biocel.2006.07.001. [DOI] [PubMed] [Google Scholar]
- 34.He G., Karin M. NF-kappaB and STAT3-key players in liver inflammation and cancer. Cell Res. 2011;21:159–168. doi: 10.1038/cr.2010.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ory L., Nazih E.H., Daoud S., Mocquard J., Bourjot M., Margueritte L., Delsuc M.A., Bard J.M., Pouchus Y.F., Bertrand S., et al. Targeting bioactive compounds in natural extracts-Development of a comprehensive workflow combining chemical and biological data. Anal. Chim. Acta. 2019;1070:29–42. doi: 10.1016/j.aca.2019.04.038. [DOI] [PubMed] [Google Scholar]
- 36.Nothias L.F., Nothias-Esposito M., da Silva R., Wang M., Protsyuk I., Zhang Z., Sarvepalli A., Leyssen P., Touboul D., Costa J., et al. Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation. J. Nat. Prod. 2018;81:758–767. doi: 10.1021/acs.jnatprod.7b00737. [DOI] [PubMed] [Google Scholar]
- 37.Schmidt J., Boettcher C., Kuhnt C., Kutchan T.M., Zenk M.H. Poppy alkaloid profiling by electrospray tandem mass spectrometry and electrospray FT-ICR mass spectrometry after [ring-13C6]-tyramine feeding. Phytochemistry. 2007;68:189–202. doi: 10.1016/j.phytochem.2006.10.003. [DOI] [PubMed] [Google Scholar]
- 38.Oh J.H., Ha I.J., Lee M.Y., Kim E.O., Park D., Lee J.H., Lee S.G., Kim D.W., Lee T.H., Lee E.J., et al. Identification and metabolite profiling of alkaloids in aerial parts of Papaver rhoeas by liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J. Sep. Sci. 2018;41:2517–2527. doi: 10.1002/jssc.201701402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hussain S.P., He P., Subleski J., Hofseth L.J., Trivers G.E., Mechanic L., Hofseth A.B., Bernard M., Schwank J., Nguyen G., et al. Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res. 2008;68:7130–7136. doi: 10.1158/0008-5472.CAN-08-0410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sharma J.N., Al-Omran A., Parvathy S.S. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15:252–259. doi: 10.1007/s10787-007-0013-x. [DOI] [PubMed] [Google Scholar]
- 41.Liu T., Zhang L., Joo D., Sun S.C. NF-kappaB signaling in inflammation. Signal Transduct. Target. Ther. 2017;2 doi: 10.1038/sigtrans.2017.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011;194:7–15. doi: 10.1083/jcb.201102095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Poljsak B., Suput D., Milisav I. Achieving the balance between ROS and antioxidants: When to use the synthetic antioxidants. Oxidative Med. Cell. Longev. 2013;2013:956792. doi: 10.1155/2013/956792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Tonelli C., Chio I.I.C., Tuveson D.A. Transcriptional Regulation by Nrf2. Antioxid. Redox Signal. 2018;29:1727–1745. doi: 10.1089/ars.2017.7342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Yu M., Li H., Liu Q., Liu F., Tang L., Li C., Yuan Y., Zhan Y., Xu W., Li W., et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal. 2011;23:883–892. doi: 10.1016/j.cellsig.2011.01.014. [DOI] [PubMed] [Google Scholar]
- 46.Hayes J.D., McMahon M., Chowdhry S., Dinkova-Kostova A.T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 2010;13:1713–1748. doi: 10.1089/ars.2010.3221. [DOI] [PubMed] [Google Scholar]
- 47.Niu X., Fan T., Li W., Xing W., Huang H. The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages. Eur. J. Pharmacol. 2012;689:262–269. doi: 10.1016/j.ejphar.2012.05.039. [DOI] [PubMed] [Google Scholar]
- 48.Wang Q., Dai P., Bao H., Liang P., Wang W., Xing A., Sun J. Anti-inflammatory and neuroprotective effects of sanguinarine following cerebral ischemia in rats. Exp. Ther. Med. 2017;13:263–268. doi: 10.3892/etm.2016.3947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yu J., Zhao L., Liu L., Yang F., Zhu X., Cao B. Tetrahydropalmatine protects rat pulmonary endothelial cells from irradiation-induced apoptosis by inhibiting oxidative stress and the calcium sensing receptor/phospholipase C-gamma1 pathway. Free Radic Res. 2016;50:611–626. doi: 10.3109/10715762.2016.1154549. [DOI] [PubMed] [Google Scholar]
- 50.Wang Y., Zhu W., Lu D., Zhang C., Wang Y. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation. Int. Immunopharmacol. 2021;100:108107. doi: 10.1016/j.intimp.2021.108107. [DOI] [PubMed] [Google Scholar]
- 51.Wu S.Z., Xu H.C., Wu X.L., Liu P., Shi Y.C., Pang P., Deng L., Zhou G.X., Chen X.Y. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway. Phytomedicine. 2019;59:152895. doi: 10.1016/j.phymed.2019.152895. [DOI] [PubMed] [Google Scholar]
- 52.Kim D.H., Lee J.H., Park S., Oh S.S., Kim S., Kim D.W., Park K.H., Kim K.D. 6-Acetonyl-5,6-dihydrosanguinarine (ADS) from Chelidonium majus L. triggers proinflammatory cytokine production via ROS-JNK/ERK-NFkappaB signaling pathway. Food Chem. Toxicol. 2013;58:273–279. doi: 10.1016/j.fct.2013.04.051. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data is contained within the article and Supplementary Materials.